Caricamento...
Challenges in randomized controlled trials and emerging multiple sclerosis therapeutics
The remarkable global development of disease-modifying therapies (DMTs) specific for multiple sclerosis (MS) has significantly reduced the frequency of relapse, slowed the progression of disability, and improved the quality of life in patients with MS. With increasing numbers of approved DMTs, neuro...
Salvato in:
| Pubblicato in: | Neurosci Bull |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5563727/ https://ncbi.nlm.nih.gov/pubmed/26480875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12264-015-1560-6 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|